WILMINGTON,PPD, Inc. reported major gains in net income for both the fourth quarter and 2002
Based on US Generall Accepted Accounting Principles (GAAP), PPD reported $169.2 million in net revenue for the fourth quarter, more than $40 million higher for the same time period in 2001.
For the year, based on GAAP, the pharmaceutical firm had net revenue of $608.7 million, 32 percent higher than 2001. Diluted earnings per share were 72 cents.
PPD also revised upward guidance for 2002, expecting net revenue between $690-$700 million, up from $685-$697.
